Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CMA1 | P23946 | 1/20 | 0.31 |
| ▸ | PPARA | Q07869 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | TTR | P02766 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6454577 | 0.80 | ALDH1A1 (0.38) | CA1CA2ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL27090346 | 0.77 | ALDH1A1 (0.38) | HPGDCA1CA2ALDH1A1SMN1; SMN2 | |
| SCHEMBL13447610 | 0.77 | LTA4H (0.48) | HPGDCA1CA2PPARA | |
| SCHEMBL12457058 | 0.77 | ST14 (0.50) | CA1CA2MAPT | |
| SCHEMBL2094817 | 0.77 | SMN1; SMN2 (0.52) | HPGDCA2ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL16669197 | 0.77 | HRH3 (0.36) | HPGDALDH1A1SMN1; SMN2LMNAMAPT | |
| SCHEMBL11561545 | 0.76 | APP (0.34) | HPGDCA2ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL1361766 | 0.74 | ALDH1A1 (0.59) | HPGDALDH1A1SMN1; SMN2MAPTPPARA | |
| SCHEMBL2095675 | 0.74 | THRB (0.53) | CA2ALDH1A1SMN1; SMN2LMNAMAPT | |
| SCHEMBL12966373 | 0.74 | HPGD (0.41) | HPGDCA1CA2ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9029840-B2 | Organic nanofiber structure based on self-assembled organogel, organic nanofiber transistor using the same, and method of manufacturing the organic nanofiber transistor | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-05-12 | — | — | US | disclosed |
| US-20130069040-A1 | ORGANIC NANOFIBER STRUCTURE BASED ON SELF-ASSEMBLED ORGANOGEL, ORGANIC NANOFIBER TRANSISTOR USING THE SAME, AND METHOD OF MANUFACTURING THE ORGANIC NANOFIBER TRANSISTOR | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2013-03-21 | — | — | US | disclosed |
| US-20100006830-A1 | Organic semiconductor compound based on 2,7-bis-(vinyl)[1]benzothieno[3,2-b]benzothiophene, organic semiconductor thin film and transistor using the same and methods of forming the same | SAMSUNG ELECTRONICS CO., LTD. | 2010-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130069040-A1 | ORGANIC NANOFIBER STRUCTURE BASED ON SELF-ASSEMBLED ORGANOGEL, ORGANIC NANOFIBER TRANSISTOR USING THE SAME, AND METHOD OF MANUFACTURING THE ORGANIC NANOFIBER TRANSISTOR | GAP43, NOTCH4, OGA | HPGD 3481/4885CA1 2234/4885CA2 4387/4885 |
| US-20100006830-A1 | Organic semiconductor compound based on 2,7-bis-(vinyl)[1]benzothieno[3,2-b]benzothiophene, organic semiconductor thin film and transistor using the same and methods of forming the same | BPNT1, TST, SULT1E1 | HPGD 4655/4885CA1 2187/4885CA2 2602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.